Showing 1 - 3 results of 3 for search 'Jonathan Kell', query time: 0.05s Refine Results
  1. 1
    Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity

    Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity by Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Sam Salek

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study

    Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study by Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Magda J. Al-Obaidi, Metod Oblak, Sam Salek

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO

    Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO by Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Magda J. Al-Obaidi, Metod Oblak, Sam Salek

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: